5EI-KOSSI M M,ZAKHAY M M.Oxidative stress in the context of acute cere-brovascular stroke[J].Stoke,2000,31(8):1889-1892.
二级参考文献28
1Kullo IJ, C, au GT, Tajik A.I. Novel risk factors for atherosclerosis. Mayo Clin Proc, 2000, 75(4) : 369 - 380.
2Namour F, Oliver J, Abdelmouttaleb I, et al. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalsmin and homocysteine concentration in blood. Blood, 2001, 97(4) : 1092 - 1098.
3Poddar R, Sivasubramanian N, Patricia M, et al. Homoeysteine induces expression and secretion of monocyte chemoattractant protein- 1 and intereukin - 8 in human aortic endothelial cells: implications for vascular disease. Circulation, 2001, 103(22) : 2717 - 2723.
4Temple ME, Luzier AB, kazierad DJ. Homocysteine as a risk factor for atherosclerosis. Ann Pharmacother , 2000, 34: 57- 65.
5Hogeveen M, Blom HJ, Van Amerongen M, et al. Hyperhomocyateinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants. J Pediatr, 141(3): 429-431.
6Aronow WS, Ahn C, Gutstein H. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons. Am J Cardiol, 2000, 86(5) : 585 - 586.
7Yoo JH, Chung CS, Kan SS. Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. Stroke, 1998, 29:2478 - 2483.
8Kelly PJ, Rosand J. Kistler JP, et al. Homocysteine, MTHFR 677C-> T polymorphism, and riak of ischemic stroke: results of a meta-analysis. Neurology, 2002, 59(4) : 529 - 536.
9Robert T, Marc A, Andre Cap, et al. Endothelial dyafunction in a murine model mild hyperhomocyst(e) inemia. J Clin Invest, 2000,106(4) : 483 - 491.
4YUDKIN J S. The Deidesheimer meeting:significance of classical and new risk factors in non-insulin-dependent diabetes mellitus[J]. J Diabetic Complications, 1997,11 (2) : 100-103.
5NISKANEN L,LAAKSO M. Insulin resistance is related to albuminuria in patients with type Ⅱ diabetes mellitus[J]. Metabonism, 1993,42 (12) : 1541-1545.
7WALKER M. Oberity,insulin resistance,and its link to non-insulin-dependent diabetes mellitus [J ]. Metab, 1995,44 (9 Suppl 3) :18-20.
8STERN M P. Diabetes and cardiovascular disease the "common soil" hypothesis[J]. Diabetes, 1995,44(4) :369-374.
9Szalat A , Raz I. Metabolic syndrome and microangiopathy. Isr Med Assoc J, 2006, (8) :424 - 425.
10P ist ro sob F, Herbr ig K, Kindel B, et al . Ro siglitazoneimp roves glomerular hyperf ih rat ion, renal endo the21ial dysfunct ion, and microalbum inur ia of incip ient di2abet ic neph ropathy in pat ients[J]. Diabetes, 2005,54:2 206-2 211.
